NEW YORK (GenomeWeb News) – Sigma-Aldrich today said that it has signed an agreement to serve as worldwide distributor of Olink Bioscience's Duolink In Situ products.

The Duolink In Situ products enable researchers to image the locations of single protein-protein interactions, measure protein expression levels, and identify relative changes in post-translational modification events.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.